Q&A: FDA's New Associate Director of Genomics Lays Out Pharmacogenomics Outlook For 2009

Issam Zineh discusses new drug labeling projects and pharmacogenomic initiatives at the Food and Drug Administration in the coming year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.